Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Renal Insufficiency × melflufen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 4 Renal Insufficiency 1 Immunoglobulin Light-chain Amyloidosis 1

Interventions

Dexamethasone 2 melflufen 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 daratumumab 1 dabrafenib 1 belinostat 1 auricularum 1 Thalidomide 1 Pharmacogenomic Testing 1 Lenalidomide 1 L-melphalanyl-p-L-fluorophenylalanine ethyl ester 1 Cyclophosphamide 1 Calcium Dobesilate 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03639610 2023-03-10

BRIDGE

Oncopeptides AB

Phase 2 Terminated

35 enrolled 33 charts

Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡